WILLIAMSON, JOHN M.D.
Pain Management · NPI 1922069186 · HUNTSVILLE, TX
WILLIAMSON, JOHN is a Pain Management in HUNTSVILLE, TX, a member of 1 medical group, who billed 31 distinct codes to Medicare Part B in 2024.
Groups: STEPHEN M SIMS MD PA (CONROE, TX)
Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒
Provider overview · all codes · CY2024
All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.
Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services | Beneficiary-episodes | Avg charge | Avg Medicare payment |
|---|---|---|---|---|---|
| J1010 | Injection, methylprednisolone acetate, 1 mg | premium | premium | premium | premium |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | premium | premium | premium | premium |
| J2704 | Injection, propofol, 10 mg | premium | premium | premium | premium |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | premium | premium | premium | premium |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 80307 | Testing for presence of drug, by chemistry analyzers | premium | premium | premium | premium |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | premium | premium | premium | premium |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| J1030 | Injection, methylprednisolone acetate, 40 mg | premium | premium | premium | premium |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | premium | premium | premium | premium |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | premium | premium | premium | premium |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | premium | premium | premium | premium |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| 20553 | Injection of trigger points, 3 or more muscles | premium | premium | premium | premium |
| G2011 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes | premium | premium | premium | premium |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | premium | premium | premium | premium |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | premium | premium | premium | premium |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | premium | premium | premium | premium |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | premium | premium | premium | premium |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | premium | premium | premium | premium |
| 20610 | Aspiration and/or injection of fluid from large joint | premium | premium | premium | premium |
| 77002 | Fluoroscopic guidance for needle placement | premium | premium | premium | premium |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | premium | premium | premium | premium |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | premium | premium | premium | premium |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | premium | premium | premium | premium |
| 62323 | Injection of substance into lower spine canal using imaging guidance | premium | premium | premium | premium |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | premium | premium | premium | premium |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | premium | premium | premium | premium |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.